These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Proceedings of the 2017 ISEV symposium on "HIV, NeuroHIV, drug abuse, & EVs". Hu G; Yelamanchili S; Kashanchi F; Haughey N; Bond VC; Witwer KW; Pulliam L; Buch S J Neurovirol; 2017 Dec; 23(6):935-940. PubMed ID: 29147885 [TBL] [Abstract][Full Text] [Related]
6. Extracellular Vesicles as a New Promising Therapy in HIV Infection. Navarrete-Muñoz MA; Llorens C; Benito JM; Rallón N Front Immunol; 2021; 12():811471. PubMed ID: 35058938 [TBL] [Abstract][Full Text] [Related]
7. HIV Maintains an Evolving and Dispersed Population in Multiple Tissues during Suppressive Combined Antiretroviral Therapy in Individuals with Cancer. Rose R; Lamers SL; Nolan DJ; Maidji E; Faria NR; Pybus OG; Dollar JJ; Maruniak SA; McAvoy AC; Salemi M; Stoddart CA; Singer EJ; McGrath MS J Virol; 2016 Oct; 90(20):8984-93. PubMed ID: 27466425 [TBL] [Abstract][Full Text] [Related]
8. Extracellular Vesicles from Infected Cells Are Released Prior to Virion Release. Kim Y; Mensah GA; Al Sharif S; Pinto DO; Branscome H; Yelamanchili SV; Cowen M; Erickson J; Khatkar P; Mahieux R; Kashanchi F Cells; 2021 Apr; 10(4):. PubMed ID: 33916140 [TBL] [Abstract][Full Text] [Related]
10. Cocaine augments neuro-inflammation via modulating extracellular vesicle release in HIV-1 infected immune cells. Narayanan M; Kulkarni R; Jiang S; Kashanchi F; Prasad A Retrovirology; 2021 Sep; 18(1):26. PubMed ID: 34530855 [TBL] [Abstract][Full Text] [Related]
11. HIV-1 Nef is released in extracellular vesicles derived from astrocytes: evidence for Nef-mediated neurotoxicity. Sami Saribas A; Cicalese S; Ahooyi TM; Khalili K; Amini S; Sariyer IK Cell Death Dis; 2017 Jan; 8(1):e2542. PubMed ID: 28079886 [TBL] [Abstract][Full Text] [Related]
12. Exosomal miR-9 Released from HIV Tat Stimulated Astrocytes Mediates Microglial Migration. Yang L; Niu F; Yao H; Liao K; Chen X; Kook Y; Ma R; Hu G; Buch S J Neuroimmune Pharmacol; 2018 Sep; 13(3):330-344. PubMed ID: 29497921 [TBL] [Abstract][Full Text] [Related]
13. Cell-Associated HIV-1 DNA and RNA Decay Dynamics During Early Combination Antiretroviral Therapy in HIV-1-Infected Infants. Uprety P; Chadwick EG; Rainwater-Lovett K; Ziemniak C; Luzuriaga K; Capparelli EV; Yenokyan G; Persaud D Clin Infect Dis; 2015 Dec; 61(12):1862-70. PubMed ID: 26270687 [TBL] [Abstract][Full Text] [Related]
14. HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial. Ensoli B; Nchabeleng M; Ensoli F; Tripiciano A; Bellino S; Picconi O; Sgadari C; Longo O; Tavoschi L; Joffe D; Cafaro A; Francavilla V; Moretti S; Pavone Cossut MR; Collacchi B; Arancio A; Paniccia G; Casabianca A; Magnani M; Buttò S; Levendal E; Ndimande JV; Asia B; Pillay Y; Garaci E; Monini P; Retrovirology; 2016 Jun; 13(1):34. PubMed ID: 27277839 [TBL] [Abstract][Full Text] [Related]
15. Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial. Loret EP; Darque A; Jouve E; Loret EA; Nicolino-Brunet C; Morange S; Castanier E; Casanova J; Caloustian C; Bornet C; Coussirou J; Boussetta J; Couallier V; Blin O; Dussol B; Ravaux I Retrovirology; 2016 Apr; 13():21. PubMed ID: 27036656 [TBL] [Abstract][Full Text] [Related]
16. Extracellular Vesicles Carry HIV Env and Facilitate Hiv Infection of Human Lymphoid Tissue. Arakelyan A; Fitzgerald W; Zicari S; Vanpouille C; Margolis L Sci Rep; 2017 May; 7(1):1695. PubMed ID: 28490736 [TBL] [Abstract][Full Text] [Related]
17. HIV Replication Increases the Mitochondrial DNA Content of Plasma Extracellular Vesicles. Bazié WW; Boucher J; Goyer B; Kania D; Traoré IT; Somé DY; Alary M; Gilbert C Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768245 [TBL] [Abstract][Full Text] [Related]
18. Changes in HIV reservoirs during long-term antiretroviral therapy. Hong FF; Mellors JW Curr Opin HIV AIDS; 2015 Jan; 10(1):43-8. PubMed ID: 25402706 [TBL] [Abstract][Full Text] [Related]
19. HIV-1 evolution in patients undergoing immunotherapy with Tat, Rev, and Nef expressing dendritic cells followed by treatment interruption. de Goede AL; van Deutekom HW; Vrancken B; Schutten M; Allard SD; van Baalen CA; Osterhaus AD; Thielemans K; Aerts JL; Keşmir C; Lemey P; Gruters RA AIDS; 2013 Nov; 27(17):2679-89. PubMed ID: 24149085 [TBL] [Abstract][Full Text] [Related]
20. HIV Replication and Latency in a Humanized NSG Mouse Model during Suppressive Oral Combinational Antiretroviral Therapy. Satheesan S; Li H; Burnett JC; Takahashi M; Li S; Wu SX; Synold TW; Rossi JJ; Zhou J J Virol; 2018 Apr; 92(7):. PubMed ID: 29343582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]